MODERN APPROACH TO INVASIVE CANDIDIASIS DIAGNOSIS AND TREATMENT IN DONOR ORGAN RECIPIENTS (PART II)
Abstract
In donor organ recipients we observe sufficiently high risk of invasive mycotic infection development and most of them are caused by Candida spp and Aspergillus spp. Clinical evidence of invasive candidiasis are diverse and this fact makes early diagnosis complicated. At the same time, despite relative frequency of invasive mycoses at transplantation, there are no definite recommendations for diagnosis, treatment and prevention of mycotic infections. In most cases physicians should rely on their own clinical experience. In the present study we demonstrated modern approaches to diagnosis and treatment for invasive candidiasis in donor organ recipients.
About the Authors
E. V. Bolotova
Kuban State Medical University, Ministry of Health of the Russian Federation; Scientific Research Institute – Ochapovsky Regional Clinical Hospital no. 1, The Krasnodar Krai Ministry of Health
Russian Federation
Russian Federation
L. V. Shulzhenko
Kuban State Medical University, Ministry of Health of the Russian Federation; Scientific Research Institute – Ochapovsky Regional Clinical Hospital no. 1, The Krasnodar Krai Ministry of Health
Russian Federation
Russian Federation
V. A. Porhanov
Kuban State Medical University, Ministry of Health of the Russian Federation; Scientific Research Institute – Ochapovsky Regional Clinical Hospital no. 1, The Krasnodar Krai Ministry of Health
Russian Federation
Russian Federation
A. E. Antinyan
Kuban State Medical University, Ministry of Health of the Russian Federation; Scientific Research Institute – Ochapovsky Regional Clinical Hospital no. 1, The Krasnodar Krai Ministry of Health
Russian Federation
Russian Federation
O. V. Bozhko
Kuban State Medical University, Ministry of Health of the Russian Federation; Scientific Research Institute – Ochapovsky Regional Clinical Hospital no. 1, The Krasnodar Krai Ministry of Health
Russian Federation
Russian Federation
A. A. Smolin
Scientific Research Institute – Ochapovsky Regional Clinical Hospital no. 1, The Krasnodar Krai Ministry of Health
Russian Federation
Russian Federation
References
1. Pappas P.G., Alexander B.D., Andes D.R., Hadley S., Kauffman C.A., Freifeld A., Anaissie E.J., Brumble L.M., Herwaldt L., Ito J., Kontoyiannis D.P., Lyon G.M., Marr K.A., Morrison V.A., Park B.J., Patterson T.F., Perl T.M., Oster R.A., Schuster M.G., Walker R., Walsh T.J., Wannemuehler K.A., Chillera T.M. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010; 50: 1101 - 1111.
2. Moreno A., Cervera C., Gavalda J., Rovira M., De La Camara R., Jarque I., Montejo M., De La Torre-Cisneros J., Miguel Cisneros J., Fortun J., Lopez-Medrano F., Gurgui M., Munoz P., Ramos A., Carratala J. Bloodstream infections among transplant recipients: results of a nationwide surveillance in Spain. Am J Transplant 2007; 7: 2579 - 2586.
3. Zicker M., Colombo A.L., Ferraz-Neto B.H., Camargo L.F. Epidemiology of fungal infections in liver transplant recipients: a six-year study of a large Brazilian liver transplantation centre. Mem Inst Oswaldo Cruz 2011; 106: 339 - 345.
4. Gavalda J., Meijel Y., Fortun J., Roilides E., Saliba F., Lortholary O., Munoz P., Grossi P., Cuenca-Estrella M. on behalf of the ESCMID Study Group for Infections in Compromised Hosts (ESGICH). Invasive fungal infections in solid organ transplant recipients. Clin Microbiol Infect 2014; 20(Suppl.7): 27 - 48.
5. Kasai M., Francesconi A., Petraitiene R., Petraitis V., Kelaher A.M., Kim H.S., Meletiadis J., Sein T., Bacher J., Walsh T.J. Use of quantitative real-time PCR to study the kinetics of extracellular DNA released from Candida albicans, with implications for diagnosis of invasive candidiasis. J Clin Microbiol 2006; 44: 143 - 150.
6. Nguyen M.H., Wissel M.C., Shields R.K., Salomoni M.A., Hao B., Press E.G., Shields R.M., Cheng S., Mitsani D., Vadnerkar A., Silveira F.P., Steven B. Kleiboeker S.B., Clancy C.J. Performance of Candida real-time polymerase chain reaction, ß-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis 2012; 54: 1240 - 1248.
7. Sendid B., Caillot D., Baccouch-Humbert B., Klingspor L., Grandjean M., Bonnin A., Poulain D. Contribution of the Platelia Candida-specific antibody and antigen tests to early diagnosis of systemic Candida tropicalis infection in neutropenic adults. J Clin Microbiol 2003; 41: 4551 - 4558.
8. Cuenca-Estrella M., Verweij P.E., Arendrup M.C., Arikan-Akdagli S., Bille J., Donnelly J.P., Jensen H.E., Lass-Flörl C., Richardson M.D., Akova M., Bassetti M., Calandra T., Castagnola E., Cornely O.A., Garbino J., Groll A.H., Herbrecht R., Hope W.W., Kullberg B.J., Lortholary O., Meersseman W., Petrikkos G., Roilides E., Viscoli C., A. J. Ullmann A.J. and for the ESCMID Fungal Infection Study Group (EFISG). ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect 2012; 18(suppl 7): 9 - 18.
9. Karageorgopoulos D.E., Vouloumanou E.K., Ntziora F., Michalopoulos A., Rafailidis P.I., Falagas M.E. ß-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis 2011; 52: 750 - 770.
10. Koo S., Bryar J.M., Page J.H., Baden L.R., Marty F.M. Diagnostic performance of the (1 3)-ß-D-glucan assay for invasive fungal disease. Clin Infect Dis 2009; 49: 1650 -1659.
11. Held J., Kohlberger I., Rappold E., Busse Grawitz A., Hacker G. Comparison of (1,3)-ß-D-glucan, mannan / anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia. J Clin Microbiol 2013; 51: 1158 - 1164.
12. De Pauw B., Walsh T.J., Donnelly J.P., Stevens D.A., Edwards J.E., Calandra T., Pappas P.G., Maertens J., Lortholary O., Kauffman C.A., Denning D.W., Patterson T.F., Maschmeyer G., Bille J., Dismukes W.E., Herbrecht R., Hope W.W., Kibbler C.C., Kullberg B.J., Marr K.A., Munoz P., Odds F.C., Perfect J.R., Restrepo A., Ruhnke M., Segal B.H., Sobel J.D., Sorrell T.C., Viscoli C., Wingard J.R., Zaoutis T., Bennett J.E. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813 - 1821.
13. Alexander B.D., Smith P.B., Davis R.D., Perfect J.R., Reller L.B. The (1,3) ß-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation. J Clin Microbiol 2010; 48: 4083 - 4088.
14. Mennink-Kersten M.A., Ruegebrink D., Verweij P.E. Pseudomonas aeruginosa as a cause of 1,3-ß-D-glucan assay reactivity. Clin Infect Dis 2008; 46: 1930 -1931.
15. Leon C., Ruiz-Santana S., Saavedra P., Castro C., Ubeda A., Loza A., Martrn-Mazuelos E., Blanco A., Jerez V., Ballûs J., Alvarez-Rocha L., Utande-Vázquez A., Farinas O. Value of ß-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions. Intensive Care Med 2012; 38: 1315 - 1325.
16. Avni T., Leibovici L., Paul M. PCR diagnosis of invasive candidiasis: systematic review and metaanalysis. J Clin Microbiol 2011; 49: 665 - 670.
17. Fortun J., Meije Y., Buitrago M. Clinical Validation of Multiplex Quantitative Real-Time PCR (RT-PCR) for Invasive Candidiasis (IC) in Patients (pts) Admitted in Intensive Care Unit (ICU). Preliminary analysis. 23rd European Congress of Clinical Microbiology and Infectious Diseases; 2013; April 27 - 30; Berlin. P. 1050.
18. Pappas P.G., Silveira F.P. Candida in solid organ transplant recipients. Am J Transplant 2009; 9(suppl4): 173 - 179.
19. Aguado J.M., Ruiz-Camps I., Munozс P., Mensad J., Almiranteb B., Vázqueze L., Roviraf M., Martrn-Dávilag P., Morenod A., Alvarez-Lermah F., Leoni C., Maderoj L., Ruiz-Contrerask J., Fortung J., Cuenca-Estrellal M. Guidelines for the treatment of invasive candidiasis and other yeasts. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2010 Update. Enferm Infecc Microbiol Clin 2011; 29: 345 - 361.
20. Pappas P.G., Kauffman C.A., Andes D., Benjamin D.K., Calandra T.F., Edwards J.E., Filler S.G., Fisher J.F., Kullberg B.J., Ostrosky-Zeichner L., Reboli A.C., Rex J.H., Walsh T.J., Sobel J.D.; Infectious Diseases Society of America. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503 - 535.
21. Pappas P.G., Rotstein C.M., Betts R.F., Nucci M., Talwar D., De Waele J.J., Vazquez J.A., Dupont B.F., Horn D.L., Ostrosky-Zeichner L., Reboli A.C., Suh B., Digumarti R., Wu C., Kovanda L.L., Arnold L.J., Buell D.N. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. Clin Infect Dis 2007; 45: 883 - 893.
22. Smego R.A. Jr, Ahmad H. The role of fluconazole in the treatment of Candida endocarditis: a meta-analysis. Medicine (Baltimore) 2011; 90: 237 - 249.
23. Boland J.M., Chung H.H., Robberts F.J., Wilson W.R., Steckelberg J.M., Baddour L.M., Miller D.V. Fungal prosthetic valve endocarditis: Mayo Clinic experience with a clinicopathological analysis. Mycoses 2011; 54: 354 - 360.
24. Guaraldi G., Cocchi S., Codeluppi M., Di Benedetto F., De Ruvo N., Masetti M., Venturelli C., Pecorari M., Pinna A.D., Esposito R. Outcome, incidence, and timing of infectious complications in small bowel and multivisceral organ transplantation patients. Transplantation 2005; 80: 1742 - 1748.
25. Gavalda J., Vidal E., Lumbreras C. Infection prevention in solid organ transplantation. Enferm Infecc Microbiol Clin 2012; 30(suppl 2): 27 - 33.
26. Gavalda J., Meije Y., Len O., Pahissa A. Invasive fungal infection in solid organ transplant. Enferm Infecc Microbiol Clin 2012; 30: 645 - 653.
27. Singh N., Paterson D.L., Gayowski T., Wagener M.M., Marino I.R. Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy. Transplantation 2001; 71: 910 - 913.
28. Saliba F., Delvart V., Ichai P., Kassis N., Botterel F., Mihaila L., Azoulay D., Adam R., Castaing D., Bretagne S., Samuel D. Fungal infections after liver transplantation: outcomes and risk factors revisited in the MELD era. Clin Transplant 2013; 27: E454 - E461.
29. Aguado J.M., Varo E., Usetti P., Pozo J.C., Moreno A., Catalán1 M., Len O., Blanes M., Solé A., Munoz P., M. Montejo M. and the TOSCANA Study Group. Safety of anidulafungin in solid organ transplant recipients. Liver Transpl 2012; 18: 680 - 685.
30. Fortun J., Martin-Davila P., Montejo M., Munoz P., Cisneros J.M., Ramos A., Aragon C., Blanes M., San Juan R., Gavalda J., Linares P. Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients. Transplantation 2009; 87: 424 - 435.
31. Sun H.Y., Cacciarelli T.V., Singh N. Micafungin versus amphotericin B lipid complex for the prevention of invasive fungal infections in high-risk liver transplant recipients. Transplantation 2013; 96: 573 - 578.
Review
For citations:
Bolotova E.V., Shulzhenko L.V., Porhanov V.A., Antinyan A.E., Bozhko O.V., Smolin A.A. MODERN APPROACH TO INVASIVE CANDIDIASIS DIAGNOSIS AND TREATMENT IN DONOR ORGAN RECIPIENTS (PART II). Innovative Medicine of Kuban. 2016;(4):54-60. (In Russ.)
Views:
304
Email this article 
